medisourceasia.com logo

FDA Regulations and Your Business

-Dr. Norman F. Estrin


About 
medisourceasia

Magazine
Industry News
Global Trends
Events Calendar
Web Links

Web Gallery

Advertising  Info

Contact

 

US FDA : The 510(k)

Advertisement

 

Archives

More...

If you  have questions related to the contents of this column, please write to Dr Norman Estrin at yourFDAconsultant@medisourceasia.com and he will try to answer you.  This column is for you and we welcome your suggestions on how to improve it.  

Dr. Norman Estrin is a recognized authority in the medical device and cosmetic industries.  He has had over 30 years of experience in directing scientific and technical and regulatory programs in these industries.  He is Regulatory Affairs Certified (“RAC”) by the Regulatory Affairs Professional Society. Dr. Estrin is the founder of ESTRIN CONSULTING GROUP, INC. (ECG).  ECG offers cost-effective, experienced consulting to medical device firms on FDA- related issues.  Its Services include preparing 510(k) and other FDA submissions, regulatory strategy development    and acting as agent and official correspondent for non-U.S. medical device companies.

For more information, contact him at yourFDAconsultant@medisourceasia.com or visit his website: http://www.yourFDAconsultant.com

LEGALLY MARKETED DEVICES

A legally marketed device can be:

  • a device that was legally marketed prior to May 28, 1976.  That is the date that the law called the Medical Device Amendments of 1976 was passed.  A device legally marketed before passage of this law is called a “preamendments device”

  • a device which has been reclassified from Class III to Class II or I (See Archives)

  • a device which has been found to be substantially equivalent to such a device through the 510(k) process.  This is the most common situation today.

  • a low risk Class III device that has no predicate that has gone through the Evaluation of Automatic Class III Designation process.  This is a new way to reclassify statutorily classified Class III products that pose low risks. It arose from passage of  a law called The Food and Drug Administration Modernization Act of 1997. More information about it can be found at http://www.fda.gov/cdrh/modact/classiii.html

SUBSTANTIAL EQUIVALENCE (SE)

A device is SE if, in comparison to a predicate device it:

  • has the same intended use as the predicate device; and

  • has the same technological characteristics as the predicate device; or

  • has different technological characteristics that do not raise new questions of safety and effectiveness and the sponsor demonstrates that the device is as safe and effective as the legally marketed device.

It is important to understand that the new device and the predicate device need not be identical.   One normally prepares a comparison table showing the how both devices compare with respect to such factors as intended use, safety, effectiveness, design, energy used or delivered, materials, performance, labeling, biocompatibility and standards.  We will go into more detail later about how we show SE.  Showing SE to FDA’s satisfaction is of crucial importance to the applicant since, once the FDA determines that a device is SE to a predicate device, then it can be marketed in the United States.

WHO SUBMITS A 510(K)

Domestic Manufacturers Introducing A Device To The U.S. Market

WHO MUST SUBMIT:
         *Finished device manufacturers that assemble a device according to their own specifications for market in the U.S.

WHO DOES NOT SUBMIT:

*Manufacturers of device unless such components are promoted for sale to an end user as replacement parts.

*Contract manufacturers that assemble devices according to someone else's specifications.  

Specification Developers Introducing a Device to the U.S. Market
A specification developer develops specifications for a finished device but has it manufactured by a contract manufacturer.  The specification developer rather than the contract manufacturer submits the 510(k).  The FDA considers specification developers to be almost the same as manufacturers.

Repackers or Relabelers Who Make Labeling Changes, or Whose Operations Significantly Affect The Device.
Repackagers or relabelers are not required to submit a 510(k) unless they significantly change the labeling or otherwise affect any condition of the device. This includes, for example, significant changes in labeling, manuals, addition or deletion of warnings or contraindications and if the packaging operation could alter the condition of the device.

Foreign Manufacturers/Exporters or U.S. Representatives Of Foreign Manufacturers/Exporters Introducing a Device to the U.S. Market.

Next time, we will continue our exploration of the 510(k).

NOTE TO READERS:

Please understand that in order to make FDA requirements more understandable, I do simplify some of the language and omit some details.  You must rely on the actual regulations-not any of my columns to ensure you meet FDA requirements.

Back | Back To Top | Next